TABLE 1.
Clinical characteristics of HIV-infected women included in this study
| Patient characteristic | Value for groupa |
P | |
|---|---|---|---|
| HAART− | HAART+ | ||
| No. | 35 | 27 | |
| Age (yr) | 32 (24-44) | 34 (23-44) | 0.3 |
| CD4 count (cells/μl) | 408 (206-919) | 630 (294-1,111) | 0.03 |
| Plasma viral load (copies/ml) | 7,800 (<50-61,000) | <50 (<50-3,900) | 0.006 |
| No. with detectable plasma HIV RNA/total no. (%) | 14/19 (73.7)b | 1/24 (4.2)c | <0.0001 |
| Genital viral load (copies/ml) | 325 (<50-28,000) | <50 (<50-430) | 0.002 |
| No. with detectable cervical HIV RNA/total no. (%) | 15/22 (68.2)b | 1/22 (4.5)c | <0.0001 |
| Duration on ARV (months) | − | 35.5 (2-80) | |
a
Except where otherwise indicated, values are medians (ranges).
b
Only 19/35 plasma and 22/35 genital supernatant samples from HAART− women were available for evaluation of plasma and cervical HIV loads, respectively.
c
Only 24/27 plasma and 22/27 genital supernatant samples from HAART+ women were available for evaluation.